Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.

Icon for Springer Icon for PubMed Central Related Articles

Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.

Ann Surg Oncol. 2018 Feb;25(2):512-519

Authors: Fayanju OM, Park KU, Lucci A

Abstract
Molecular genomic testing provides clinicians with both prognostic and (sometimes) predictive information that can help individualize treatment and decrease the risk of over- or under-treatment. We review the genomic tests that are currently available for clinical use in management of breast cancer, discuss ongoing research related to validating and expanding their utility in different patient populations, and explain why it is important for surgeons to know how to incorporate these tools into their clinical practice in order to individualize patient treatment, reduce unnecessary morbidity, and, accordingly, improve outcomes.

PMID: 29159748 [PubMed – indexed for MEDLINE]